Richard Berges1, Matthias Oelke. 1. Department of Urology, PAN-Klinik, Zeppelinstr. 1, 50667, Cologne, Germany. r.berges@pan-klinik.org
Abstract
PURPOSE: To establish age-stratified normal values for prostate volume, serum total prostate-specific antigen (PSA) concentration, maximum urinary flow rate (Q (max)), micturition and postvoid residual urine volumes, IPSS, and quality of life. These community-derived values of healthy older men are necessary to correctly judge patients with lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH). METHODS: Analysis of LUTS/BPH-related determinants in community-dwelling men in the city of Herne, Germany after exclusion of subgroups with co-morbidities or co-medications with possible influence on the key items. RESULTS: The analysis is based on 1,763 participants. In these men aged 50-80 years, mean total prostate volume continuously increased from 24 to 38 cc and mean PSA concentration from 1.1 to 2.5 ng/ml. PSA concentration in men with a prostate volume <25 cc also showed a continuous increase with aging, starting at 0.8 in the youngest and ending at 1.9 ng/ml in the oldest age group. Mean Q (max) of free uroflowmetry (from 22.1 to 13.7 ml/s) and mean micturition volume (from 329 to 193 cc) showed a continuous decrease that was dependent on prostate size. Mean postvoid residual urine was nearly unchanged over the age groups at approximately 20-30 cc. Although IPSS increased continuously with aging (from 4 to 7), QoL remained unchanged at 2 over the age groups. Prostate size had a minor impact on IPSS. CONCLUSIONS: Normal values for investigated LUTS/BPH-related determinants and the influence of aging hereon should serve as references during the assessment of Caucasian patients in Europe.
PURPOSE: To establish age-stratified normal values for prostate volume, serum total prostate-specific antigen (PSA) concentration, maximum urinary flow rate (Q (max)), micturition and postvoid residual urine volumes, IPSS, and quality of life. These community-derived values of healthy older men are necessary to correctly judge patients with lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH). METHODS: Analysis of LUTS/BPH-related determinants in community-dwelling men in the city of Herne, Germany after exclusion of subgroups with co-morbidities or co-medications with possible influence on the key items. RESULTS: The analysis is based on 1,763 participants. In these men aged 50-80 years, mean total prostate volume continuously increased from 24 to 38 cc and mean PSA concentration from 1.1 to 2.5 ng/ml. PSA concentration in men with a prostate volume <25 cc also showed a continuous increase with aging, starting at 0.8 in the youngest and ending at 1.9 ng/ml in the oldest age group. Mean Q (max) of free uroflowmetry (from 22.1 to 13.7 ml/s) and mean micturition volume (from 329 to 193 cc) showed a continuous decrease that was dependent on prostate size. Mean postvoid residual urine was nearly unchanged over the age groups at approximately 20-30 cc. Although IPSS increased continuously with aging (from 4 to 7), QoL remained unchanged at 2 over the age groups. Prostate size had a minor impact on IPSS. CONCLUSIONS: Normal values for investigated LUTS/BPH-related determinants and the influence of aging hereon should serve as references during the assessment of Caucasian patients in Europe.
Authors: Ian M Thompson; Chen Chi; Donna Pauler Ankerst; Phyllis J Goodman; Catherine M Tangen; Scott M Lippman; M Scott Lucia; Howard L Parnes; Charles A Coltman Journal: J Natl Cancer Inst Date: 2006-08-16 Impact factor: 13.506
Authors: Esther T Kok; Arthur M Bohnen; J L H Ruud Bosch; Siep Thomas; Frans P M J Groeneveld Journal: Qual Life Res Date: 2006-07-07 Impact factor: 4.147
Authors: Annie Hutchison; Richard Farmer; Christopher Chapple; Richard Berges; Ludger Pientka; Pierre Teillac; Andrzej Borkowski; Piotr Dobronski Journal: Eur Urol Date: 2006-05-19 Impact factor: 20.096
Authors: C G Roehrborn; C J Girman; T Rhodes; K A Hanson; G N Collins; S M Sech; S J Jacobsen; W M Garraway; M M Lieber Journal: Urology Date: 1997-04 Impact factor: 2.649
Authors: Michael M Lieber; Debra J Jacobson; Michaela E McGree; Jennifer L St Sauver; Cynthia J Girman; Steven J Jacobsen Journal: J Urol Date: 2009-10-17 Impact factor: 7.450
Authors: Esther Tanja Kok; Boris W Schouten; Arthur M Bohnen; Frans P M W Groeneveld; Siep Thomas; J L H Ruud Bosch Journal: J Urol Date: 2008-12-16 Impact factor: 7.450
Authors: Claus G Roehrborn; Reginald Bruskewitz; J Curtis Nickel; John D McConnell; Brian Saltzman; Marc C Gittelman; Gholem H Malek; James E Gottesman; Shilaja Suryawanshi; Jennifer Drisko; Alan Meehan; Joanne Waldstreicher Journal: J Urol Date: 2004-03 Impact factor: 7.450
Authors: Benjamin C Trumble; Jonathan Stieglitz; Daniel Eid Rodriguez; Edhitt Cortez Linares; Hillard S Kaplan; Michael D Gurven Journal: J Gerontol A Biol Sci Med Sci Date: 2015-04-28 Impact factor: 6.053